Buying pressure lifts Johnson & Johnson higher in today trading

Buying pressure lifts Johnson & Johnson higher in today trading
Johnson & Johnson rises 2.18% today

Johnson & Johnson (JNJ) shares are trading at $246.10, well above the MA-20 ($227.72), MA-50 ($215.21), and MA-200 ($182.95), signaling a strong bullish trend across all key timeframes. Today, the price is up $5.24, or 2.18%, near the session high with elevated volatility.

JNJ price prediction
24H 0.51%
$236.48
48H 0.88%
$237.34
7D 0.72%
$236.97
1M 4.2%
$245.15
3M 12.16%
$263.88
6M 24.89%
$293.84
12M 52.41%
$358.57
Current price: $ 235.27 -0.3900 0.17%
Closed 06/16
Daily range 231.12 Arrow from to Icon 235.92
Weekly range 233.58 Arrow from to Icon 241.60
Loading...

Highlights

  • Johnson & Johnson reported quarterly earnings of $2.46 per share on $24.56 billion revenue and raised its dividend for a 63rd consecutive year.
  • Capital World Investors initiated a $2.0 billion stake while institutional investors and hedge funds now own approximately 69.55% of the company.
  • Shares trade at $246.10, well above MA-20 ($227.72), with robust bullish momentum but overbought RSI (82.15), and key resistance near $250.

Investor flows shift after earnings beat and dividend hike

Johnson & Johnson reported quarterly earnings of $2.46 per share on revenue of $24.56 billion and raised its dividend for the 63rd consecutive year, highlighting strong operational performance. Capital World Investors opened a $2.0 billion stake in the company, while Jensen Investment Management Inc. significantly reduced its holdings, and Lifestyle Asset Management Inc. increased its position by 3.4%. Institutional investors and hedge funds now own approximately 69.55% of the company.
Anton Kharitonov, expert at Traders Union, notes that Johnson & Johnson's price sits at extended highs far above major moving averages. He sees the sharp rise and consistently overbought signals as warning signs, especially with RSI and other oscillators pointing to unsustainable momentum. Kharitonov also highlights elevated volatility, saying recent institutional activity is mixed — new inflows offset by meaningful reductions. He cautions that aggressive bullishness may falter if $247 support fails. "Despite strong earnings and a dividend hike, I believe these overbought technicals suggest risk for near-term correction," he warns.
Viktoras Karapetjanc, expert at Traders Union, believes Johnson & Johnson’s upgraded dividend and fresh capital inflows reflect robust shareholder confidence. He points to sustained buying from large institutions and the company’s record of operational strength. Karapetjanc notes that the bullish structure remains intact, with the price showing strong momentum and clear consolidation potential above $247. "Given the solid fundamentals and broad institutional support, I expect further growth and new highs if momentum holds," he says.

Bullish momentum persists as overbought signals and volatility rise

The current price stands well above all reference moving averages, reflecting multi-timeframe momentum. The nearest dynamic support is given by the Ichimoku Kijun at $222.52, with major resistance found at the psychological $250 level. Momentum indicators — MACD and ADX — confirm ongoing bullish strength. At the same time, overbought signals are appearing across oscillators: RSI is at 82.15, Stoch RSI near 72, and CCI above 113, while BBP and the Awesome Oscillator continue to favor buyers. High volatility and intraday bullish drives are present, but notable overbought conditions point to short-term risks. Previously it was reported that Johnson & Johnson is exhibiting strong bullish momentum, trading decisively above all major moving averages with technical trend indicators such as MACD, ADX, and the Awesome Oscillator confirming the uptrend. However, the stock is showing pronounced overbought signals on weekly RSI, Stochastic RSI, and CCI, with resistance developing near recent highs and initial support established just below current levels, indicating potential for further gains but elevated risk of a near-term consolidation or retracement.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.